Antoxerene Inc., of Lafayette, N.Y., a portfolio company of Ichor Therapeutics Inc., said it launched a joint venture with Juvenescence Ltd., called Foxbio Inc., which will develop Antoxerene's collection of small molecules targeting senescent cells.